News
Forbes: May Mobility Is Deploying Self-Driving Vehicles Now, Starting In Detroit
6/27/2018The resurgent city of Detroit, which lost 64 percent of its population between 1950 and 2017, is experiencing something it hasn’t seen in decades: urban congestion. With little public transportation, virtually everyone in the Motor City drives to work, creating traffic and parking challenges, especially downtown. No one knows this...
Self-driving shuttle startup May Mobility partners with auto supplier Magna
6/14/2018Magna, one of the largest tier-one automotive industry suppliers in the world, has teamed up with Michigan-based startup May Mobility for the building and deployment of self-driving shuttles. The plan is to scale May Mobility’s self-driving shuttle fleet across the U.S. The initial fleet will debut for passengers on June...
Developing a Breakthrough Cancer Vaccine
6/12/2018“A transformational opportunity,” is how entrepreneur and business development specialist William Brinkerhoff describes EVOQ’s potential impact on cancer vaccine technology. He goes on to explain that, although cancer vaccines have made substantial progress, especially in the area of personalized vaccines, there remains a fundamental need for better vaccine delivery. “A...
Improving Diagnostics and Treatment for Functional Bowel Disease
6/12/2018According to recent statistics, at least 1 in every 4 Americans suffers from some form of functional gastrointestinal disease (FGID). These debilitating disorders range from dyspepsia to Irritable Bowel Syndrome (IBS). In some instances, the more devastating chronic inflammatory disorder called Crohn’s Disease can present in the early stages like...
Cellectar receives orphan drug designation for CLR 131 to treat rhabdomyosarcoma, a rare pediatric cancer
5/11/2018Cellectar Biosciences has announced that the U.S. Food and Drug Administration (FDA) granted orphan drug designation to CLR 131 for the treatment of rhabdomyosarcoma, a rare pediatric cancer. CLR 131 is the company’s lead Phospholipid Drug Conjugate (PDC) product candidate, and exploits the tumor-targeting properties of the company’s proprietary phospholipid...
U-M startup Give and Take in Inc… “How to Build a Better Company With More Engaged Employees in Just 5 Minutes a Day”
5/7/2018Givitas can make asking for and getting help from other employees simple — which can make your business a lot more efficient and effective. Asking for help can make you feel insecure. Asking for help can make you feel vulnerable. Asking for help — especially inside internally competitive organizations —...
NanoBio closes $10M funding round, changes name to BlueWillow Biologics, and plans to take NanoVax nasal spray vaccine platform into clinical trials
5/7/2018Ann Arbor-based NanoBio Corp., considered by many as perhaps the most successful fundraiser in the history of state tech startups, has raised another funding round as it makes a pivot in search of a profitable market for its molecular technology. The pivot is drastic enough that it includes renaming itself...
Boston Scientific buys U-M startup Securus for $40M to add to heart imaging lineup
4/6/2018Medical device giant Boston Scientific has acquired Securus Medical Group, a startup with FDA-cleared technology that measures and images temperature in the body during heart rhythm procedures. Marlborough, MA-based Boston Scientific (NYSE: BSX) said Tuesday that it paid $40 million up front for the stake in Securus that it did...
TIME: U-M’s nasal flu vaccine, FluMist, is set to come back next year
3/21/2018After a two-year hiatus, the nasal flu vaccine is set to return to doctors’ offices next year. The Advisory Committee on Immunization Practices (ACIP) voted 12 to 2 on Wednesday to return the nasal spray to the CDC’s list of recommended vaccines for the 2018-2019 flu season. Pending final approval...
U-M startup ViewPoint Therapeutics raises $35 Million in Series B financing
3/16/2018ViewPoint Therapeutics, Inc., a privately-held biotechnology company pioneering the development of crystallin stabilizers to prevent and treat cataracts and presbyopia, today announced the closing of a $35 million Series B financing. The financing was led by The Rise Fund with participation from Novo Holdings A/S. Additional participants included ViewPoint’s existing...
U-M startup Diamond Kinetics releases PitchTracker for baseball pitching data
3/16/2018Diamond Kinetics has expanded beyond its roots as a bat sensor company with a new smart baseball and PitchTracker app to collect data on an athlete’s pitching mechanics. A small sensor is embedded into the core of each baseball and generates six metrics on every throw: velocity, spin rate, extension...
Bose launches $50M fund for startups integrating its new audio-focused AR tech, invests in U-M mems microphone startup Vesper
3/16/2018The high-end audio technology company Bose is getting into the augmented reality game with a new product and a $50 million fund devoted to startups that will develop services for its new platform. While most of the industry is focused on a visually augmented experience, Bose is most concerned with...